SNOA
Sonoma Pharmaceuticals, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$1.33
+0.38%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 18.57x
- P/E 2028E
- —
- P/S forward
- 0.38x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.96x
- Price / sales
- 0.29x
- Price / cash flow
- -3.13x
Enterprise value
- Enterprise value
- $1.7M
- EV / sales
- 0.08x
- EV / EBITDA
- -1.10x
- EV / EBIT
- -1.24x
- Market cap
- $6.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026